Acesso livre
Acesso livre

Interesse Geral

Relatório do CDC | Vacina da Moderna está associada a alta efetividade (93%) contra hospitalização por Covid-19 em comparação às vacinas da Pfizer (88%) e da J&J (71%).

20 Set, 2021 | 13:59h

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021 – CDC Morbidity and Mortality Weekly Report

Comentários:

Moderna’s vaccine is the most effective, but Pfizer and J&J also protect well, CDC-led study says – CNN

CDC: Moderna COVID vaccine most protective against hospital cases – CIDRAP

CDC data: Moderna vaccine has edge in preventing COVID-19 hospitalizations – UPI

 

Comentário no Twitter

 


Revisão | Sintomas de “long COVID” em crianças raramente persistem por mais de 3 meses.

20 Set, 2021 | 13:57h

Comunicado de imprensa: Long COVID symptoms in children rarely persist beyond three months –  Murdoch Children’s Research Institute

Estudo original: How Common Is Long COVID in Children and Adolescents? – The Pediatric Infectious Disease Journal

Comentário: Long Covid in children and adolescents is less common than previously feared – The Guardian

Conteúdos relacionados:

Cohort study: long term follow-up showed most patients with post–COVID-19 Multisystem Inflammatory Syndrome in Children had good outcomes with no significant medium- or long-term sequelae.

Long COVID: the physical and mental health of children and non-hospitalized young people after SARS-CoV-2 infection – one in seven children may still have symptoms 15 weeks after infection.

Do kids get long COVID? And how often? A pediatrician looks at the data – Children also get Long Covid, but much less often than adults.

Illness duration and symptom profile in symptomatic school-aged children tested for SARS-CoV-2 – “Only 25 (1.8%) of 1379 children experienced symptoms for at least 56 days.”

Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents – “This study found a low prevalence of symptoms compatible with long COVID in a randomly selected cohort of children assessed 6 months after serologic testing”.

Study shows low incidence of post-acute COVID-19 symptoms (“Long Covid”) in children after mild disease

Cohort study: Risk factors for long covid in previously hospitalized children.

M-A: More than 50 long-term effects of COVID-19.

 

Comentário no Twitter (fio – clique para saber mais)

 


Um painel da FDA afirma que somente americanos de alto risco e os maiores de 65 anos deveriam tomar as doses de reforço contra Covid.

20 Set, 2021 | 13:56h

An FDA Panel Says Only High-Risk Americans And Those 65+ Should Get COVID Boosters – NPR

Ver também:

FDA advisory panel recommends booster doses of Covid-19 vaccine only for older and high-risk Americans – STAT

5 reasons why FDA advisers did not recommend Covid-19 booster shots for everyone – CNN

Top doctors say not so fast to Biden’s boosters-for-all plan – Associated Press

Conteúdos relacionados:

An observational study in Israel suggests additional protection from a 3rd dose of the Pfizer vaccine in individuals 60 years of age or older.

Third shot: UK to offer COVID booster jabs to over 50s.

COVID-19 vaccine efficacy does not support boosters for general population, review concludes.

COVID vaccine effects wane over time but still prevent death and severe illness.

What’s the evidence for COVID-19 booster shots?

WHO appeals for countries to postpone COVID-19 vaccine boosters until 2022 to prioritize vaccinating the most at-risk people around the world who are yet to receive their first dose.

AstraZeneca bosses warn against rush for boosters – “giving the most vulnerable, who may not have built up a full immune response from the first two, a third, top-up dose is “sensible”. But any decision to give a third, booster jab “to large swathes of the population”, to extend their protection from the first two, must be based on clinical data”.


Todos precisam de dose de reforço? – “Por que algumas pessoas poderiam precisar de uma dose de reforço de vacina contra Covid-19 – e outras, não.”

20 Set, 2021 | 13:54h

Does everybody need a booster shot? – Vox


Opinião | Vacinar o mundo antes de começar as doses de reforço contra COVID – “Menos de 0,5% das doses de vacina foram distribuídas a pessoas de países de baixa renda.”

20 Set, 2021 | 13:53h

Vaccinate the World before Starting COVID Booster Shots – Scientific American

Conteúdo relacionado: WHO appeals for countries to postpone COVID-19 vaccine boosters until 2022 to prioritize vaccinating the most at-risk people around the world who are yet to receive their first dose.


Imunidade conferida pela vacina contra COVID está caindo: o quanto isso importa? – “Enquanto os debates sobre as doses de reforço se acirram, o que se sabe sobre a duração da imunidade baseada em vacina ainda está em evolução.”

20 Set, 2021 | 13:51h

COVID vaccine immunity is waning — how much does that matter? – Nature


Editorial | Saúde cerebral e seus determinantes sociais.

20 Set, 2021 | 13:44h

Brain health and its social determinants – The Lancet

 

Comentário no Twitter

 


Comprovantes de vacinação estão chegando. Mas eles são éticos?

17 Set, 2021 | 13:05h

Vaccine passports are coming. But are they ethical? – The Conversation

Conteúdos relacionados:

Infographic: Vaccine passports around the world.

WHO panel comes out against requiring vaccination proof for travel

Opinion | How to lose friends and alienate people? On the problems of vaccine passports (vários textos sobre o tema)


Como a impressionante capacidade de replicação da variante Delta lança novos desafios sobre a pandemia de Covid-19.

17 Set, 2021 | 13:04h

How the Delta variant’s remarkable ability to replicate threw new twists into the Covid-19 pandemic – STAT


Diretriz AAN | Considerações éticas sobre o diagnóstico e o cuidado da demência.

17 Set, 2021 | 12:59h

Ethical Considerations in Dementia Diagnosis and Care: AAN Position Statement – Neurology


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.